CAR-T Cell Therapy Shows Potential for Long-Term HIV Management
Original framing: “Supercharging Immune Cells May Help Control HIV Long-Term” — Wired
CAR-T cell therapy represents a significant scientific advancement in immunotherapy, but its application to HIV is still in early stages. More research is needed to assess long-term safety, efficacy, and scalability, particularly in diverse populations and resource-limited settings.
The potential of CAR-T cell therapy for HIV is significant, but its success depends on addressing systemic barriers such as health inequity, cultural relevance, and global access.
By integrating indigenous knowledge, historical awareness, and cross-cultural perspectives, we can develop more inclusive and effective treatment models. Public-private partnerships and community-driven research are essential for ensuring that technological advancements translate into real-world benefits for all populations. The trickster’s perspective reminds us to question the assumptions underlying biomedical innovation and to prioritize justice over profit.